Endocrine sequelae of cancer therapy

European Journal of Endocrinology

Volumn 135, Issue 2, 1996, Pages 135-143

  Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INTERLEUKIN 2; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

CANCER; ENDOCRINE DISEASE; GROWTH RETARDATION; GYNECOMASTIA; HUMAN; HYPOGONADISM; INFERTILITY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REVIEW;

EID: 0029816360     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350135     Document Type: Review

References (46)

1. Teinturier C, Tournade MF, Caillat-Zucman S, Boitard C, Amoura Z, Bougneres, PF, et al. Diabetes mellitus after abdominal irradiation therapy. Lancet 1995;346:633-4
2. Shalet SM. Radiation and pituitary dysfunction. N Engl J Med 1993;328:131-3
3. Sanders JE, Buckner CD, Sullivan KM, Doney K, Appelbaum F, Witherspoon R, et al. Growth and development in children after bone marrow transplantation. Horm Res 1988;30:92-7
4. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 1989;262:145-60
5. Chieng PU, Huang TS, Chang CC, Chong PN, Tien RD, Su CT. Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: spect studies in 34 patients. Am J Nucl Radiol 1991;12:661-5
6. Ogilvy-Stuart AL, Wallace WHB, Shalet SM. Radiation and neuroregulatory control of growth hormone secretion. Clin Endocrinol 1994;41:163-8
7. Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol 1989;31:363-73
8. Shalet SM, Price DA, Beardwell CG, Jones PH, Pearson D. Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukaemia. J Pediatr 1979;94:719-22
9. Toogood AA, Ryder WDJ, Beardwell CG, Shalet SM. The evolution of radiation-induced growth hormone in adults is determined by the baseline growth hormone status. Clin Endocrinol 1995;43: 97-103
10. Ogilvy-Stuart AL, Clayton PE, Shalet SM. Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994;78:1282-6
11. Duffy BJ, Fitzgerald PJ. Thyroid cancer in childhood and adolescence. Cancer 1950;3:1018-32
12. DeGroot LJ. Diagnostic approach and management of patients exposed to irradiation to the thyroid. J Clin Endocrinol Metab 1989;69:925-8
13. Maxon HR, Thomas SR, Saenger EL, Buncher CR, Kereiakes JG. Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland. Am J Med 1977;63:967-78
14. Ron E, Modan B, Preston D, Alfandary E, Stovall M, Boice JD. Thyroid neoplasia following low-dose radiation in childhood. Radiat Res 1989;120:516-31
15. Moroff SV, Fuks JZ. Thyroid cancer following radiotherapy for Hodgkin's disease: a case report and review of the literature. Med Pediatr Oncol 1986;14:216-20
16. Samaan NA, Schultz PN, Ordonez NG, Hickey RC, Johnston DA. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 1987;64:219-23
17. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Cancer 1994;74:748-66
18. Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster. Implications for the study of radiation tumourigenesis. J Clin Endocrinol Metab 1996;81:9-14
19. Williams D. Thyroid cancer and the Chernobyl accident. J Clin Endocrinol Metab 1996;81:6-8
20. Fogelfeld L, Wiviott MBT, Shore-Freedman E, Blend M, Bekerman C, Pinsky S, et al. Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions. N Engl J Med 1989;320:835-40
21. Schimpff SC, Diggs Ch, Wiswell JG, Salvatore PC, Wienik PH. Radiation-related thyroid dysfunction: implications for the treatment of Hodgkin's disease. Ann Intern Med 1980;92:91-8
22. Shalet SM, Didi M, Ogilvy-Stuart AL, Schulga J, Donaldson MDC. Growth and endocrine function after bone marrow transplantation. Clin Endocrinol 1995;42:333-9
23. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988;318: 1557-63
24. Livesey EA, Brook CGD. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989;64: 593-5
25. Ogilvy-Stuart AL, Shalet SM, Gattamaneni HRG. Thyroid function following the treatment of brain tumours in children. J Pediatr 1991;119:733-7
26. Rao SD, Frame B, Miller MJ, Kleerekoper M, Block MA, Parfitt AM. Hyperparathyroidism following head and neck irradiation. Arch Intern Med 1980;140:205-7
27. RUSS JE, Scanlon EF, Sener SF. Parathyroid adenomas following irradiation. Cancer 1979;43:1078-83
28. Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E, Lubin J. Dose-dependent relationships for radiation-induced hyperparathyroidism. J Clin Endocrinol Metab 1995;80:254-7
29. Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses in ionising radiation on the human testis. Radiat Res 1974;59:665-78
30. Hahn EW, Feingold SM, Nisce L. Aspermia and recovery of spermatogenesis in cancer patients following incidental gonadal irradiation during treatment: a progress report. Radiology 1976;119:223-5
31. Hahn EW, Feingold SM, Simpson L, Batata M. Recovery from aspermia induced by low-dose radiation in seminoma patients. Cancer 1982;50:337-40
32. Shalet SM, Tsatsoulis A, Whitehead E, Read G. Vulnerability of the human Leydig cell to radiation damage is dose-dependent. J Endocrinol 1989;120:161-5
33. Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991;287:265-74
34. Doll R, Smith PG. The long-term effects of X-irradiation in patients treated for metropathia haemorrhagica. Br J Radiol 1968;41: 362-8
35. Wallace WHB, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR. Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br Radiol 1989;62:995-8
36. Li FP, Gimbrere K, Gelber RD, Sallan SE, Flamant F, Green DM, et al. Outcome of pregnancy in survivors of Wilm's tumour. J Am Med Assoc 1987;257:216-9
37. Critchley HOD, Wallace WHB, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood: the potential for pregnancy. Br J Obstet Gynaecol 1992;99:392-4
38. Watson AR, Rance CP, Bain J. Long-term effects of cyclophosphamide on testicular function. Br Med J 1985;291:1457-60
39. Chapman RM, Sutcliffe SB, Rees LH, Edwards CRW, Malpas JC. Cyclical combination chemotherapy and gonadal function. Lancet 1979;1:285-9
40. Whithead E, Shalet SM, Blackledge G, Todd T, Crowther D, Beardwell CG. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 1982;49:418-22
41. Holmes SJ, Whitehouse RW, Clark ST, Crowther DC, Adams JE, Shalet SM. Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. Br J Cancer 1994;70:371-5
42. Uldall PR, Kerr DNS, Tacchi D. Sterility and cyclophosphamide. Lancet 1972;1:693-4
43. Koyama H, Wada T,Nishizaw Y, Iwanaga T, Aoki Y, Teresawa T, et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39:1403-9
44. Walden PAM, Bagshawe KD. Pregnancies after chemotherapy for gestational trophoblastic tumours. Lancet 1979;11:1241
45. Chatterjee R, Mills W, Katz M, McGarrigle HH, Goldstone AH. Prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in postmenarchial female patients. Bone Marrow Transplant 1994;13:511-7
46. Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, et al. Ovarian function following marrow transplantation for aplastic anaemia or leukaemia. J Clin Oncol 1988;6:813-8